Algert Global LLC lifted its stake in shares of Constellium SE (NYSE:CSTM - Free Report) by 636.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 235,897 shares of the industrial products company's stock after acquiring an additional 203,857 shares during the period. Algert Global LLC owned approximately 0.17% of Constellium worth $2,380,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the stock. Boston Partners increased its position in shares of Constellium by 3.2% during the first quarter. Boston Partners now owns 135,436 shares of the industrial products company's stock worth $1,367,000 after acquiring an additional 4,164 shares in the last quarter. Russell Investments Group Ltd. grew its position in Constellium by 79.2% in the first quarter. Russell Investments Group Ltd. now owns 504,020 shares of the industrial products company's stock valued at $5,086,000 after purchasing an additional 222,690 shares in the last quarter. Nuveen LLC bought a new position in Constellium in the first quarter valued at $19,630,000. Invesco Ltd. grew its position in Constellium by 3.7% in the first quarter. Invesco Ltd. now owns 137,150 shares of the industrial products company's stock valued at $1,384,000 after purchasing an additional 4,922 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. grew its position in Constellium by 858.6% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 242,879 shares of the industrial products company's stock valued at $2,451,000 after purchasing an additional 217,541 shares in the last quarter. Institutional investors own 92.59% of the company's stock.
Constellium Stock Up 0.4%
Constellium stock traded up $0.06 during mid-day trading on Wednesday, reaching $14.62. The company's stock had a trading volume of 934,079 shares, compared to its average volume of 1,372,501. The company has a market capitalization of $2.04 billion, a price-to-earnings ratio of 76.93 and a beta of 1.69. Constellium SE has a 12 month low of $7.32 and a 12 month high of $17.27. The business's 50 day simple moving average is $13.89 and its 200 day simple moving average is $11.91. The company has a debt-to-equity ratio of 2.47, a quick ratio of 0.53 and a current ratio of 1.23.
Constellium (NYSE:CSTM - Get Free Report) last released its earnings results on Tuesday, July 29th. The industrial products company reported $0.25 earnings per share for the quarter, missing analysts' consensus estimates of $0.28 by ($0.03). The business had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $2.08 billion. Constellium had a net margin of 0.37% and a return on equity of 3.43%. As a group, research analysts anticipate that Constellium SE will post 1.1 earnings per share for the current year.
Constellium Profile
(
Free Report)
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
See Also

Before you consider Constellium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.
While Constellium currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.